These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Treatment of advanced respiratory insufficiency using potassium canreonate (Aldactone). Preliminary report]. Kerjaschki A Wien Med Wochenschr; 1976 Dec; 126(49-50):705-7. PubMed ID: 795170 [No Abstract] [Full Text] [Related]
8. [Interference of canrenoate potassium with plasma renin activity. Note I. Effects of canrenoate potassiumon plasma renin activity in patients with essential hypertension]. Consolo F; Ferraù O; Pitrone F; Luzza G; Russo A; Virga T Boll Soc Ital Biol Sper; 1975 Dec; 51(24):1943-9. PubMed ID: 1231877 [No Abstract] [Full Text] [Related]
9. Treatment of digitalis toxicity with intravenous potassium canrenoate. Gavrilescu G; Cristodorescu R; Deutsch G; Berger E Agressologie; 1977; 18(3):167-71. PubMed ID: 920909 [No Abstract] [Full Text] [Related]
10. The effect of intravenous potassium canrenoate in patients with severe heart failure and digitalis toxicity. Cristodorescu R; Puschita M; Deutsch G; Berger E; Luca C Med Interne; 1977; 15(1):27-34. PubMed ID: 841250 [TBL] [Abstract][Full Text] [Related]
11. [Effectiveness of K canrenoate in the treatment of secondary hyperaldosteronism]. Tartagni F; Pasetti L; Ambrosioni E; Magnani B G Clin Med; 1979 Mar; 60(3):196-206. PubMed ID: 520727 [No Abstract] [Full Text] [Related]
12. [Controlled study of the effect of long-term administration of canrenoate potassium in cirrhotic ascites]. Traina M; Vizzini GB Minerva Med; 1986 Jan; 77(3-4):87-91. PubMed ID: 3511409 [TBL] [Abstract][Full Text] [Related]
13. [Use of canrenoate potassium given orally in ascitogenic cirrhosis]. Sarti F; Milandri GL; Piemontese A; Macchia S; Simoni S; Dal Monte PR Minerva Dietol Gastroenterol; 1984; 30(3):273-80. PubMed ID: 6504377 [No Abstract] [Full Text] [Related]
14. [Effect of potassium canrenoate on arterial pressure, plasma renin activity and urinary aldosterone in essential hypertension]. Opocher G; Armanini D; Fallo F; Mantero F Boll Soc Ital Cardiol; 1978; 23(10):1757-66. PubMed ID: 400390 [No Abstract] [Full Text] [Related]
15. [Value of Soludactone in cardiac surgery in adults]. Fogliani J; Capuccio P; Goudard A; Guillen JC; Monties JR Ann Anesthesiol Fr; 1975; 16(3):189-96. PubMed ID: 241276 [TBL] [Abstract][Full Text] [Related]
16. [Evaluation of K-canrenoate in post-surgical treatment of open heart paediatric surgery (author's transl)]. Capuani A; Bernabei M; Pasque A; Eufrate S G Ital Cardiol; 1980; 10(9):1148-55. PubMed ID: 7461364 [TBL] [Abstract][Full Text] [Related]
17. [Antihypertensive efficacy and effects on intra and extracellular electrolytes of a canrenoate potassium-butizide combination]. Costa FV; Borghi C; Mussi A; Ambrosioni E Minerva Cardioangiol; 1988 Oct; 36(10):503-7. PubMed ID: 3226562 [No Abstract] [Full Text] [Related]
18. Clinical study of potassium canrenoate on raised intracranial pressure. Node Y; Nakazawa S Adv Neurol; 1990; 52():557. PubMed ID: 2396562 [No Abstract] [Full Text] [Related]
19. [The use of an injectable anti-aldosteron agent in the treatment of secondary hyperaldosteronism]. Tartagni F; Ambrosioni E Boll Soc Ital Cardiol; 1976; 21(4):725-7. PubMed ID: 1031037 [No Abstract] [Full Text] [Related]
20. Comparative clinical study of spironolactone and potassium canrenoate. A randomized evaluation with double cross-over. Emili M; Cuppone R; Ricci GL Arzneimittelforschung; 1988 Oct; 38(10):1492-5. PubMed ID: 3058132 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]